Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CYCCP - Cyclacel Pharmaceuticals Inc - 6% PRF PERPETUAL USD 10


Previous close
8.87
0   0%

Share volume: 1,134
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$8.87
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
-17.85%
1 Month
-23.71%
3 Months
6.94%
6 Months
-56.70%
1 Year
-41.02%
2 Year
26.05%
Key data
Stock price
$8.87
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$5.21 - $22.20
52 WEEK CHANGE
-$0.41
MARKET CAP 
2.077 M
YIELD 
3.73%
SHARES OUTSTANDING 
1.259 K
DIVIDEND
$0.15
EX-DIVIDEND DATE
01/19/2024
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,179
AVERAGE 30 VOLUME 
$1,673
Company detail
CEO: Spiro Rombotis
Region: US
Website: http://www.cyclacel.com/
Employees: 15
IPO year: -
Issue type:
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

cyclacel limited is a pharmaceuticals company located in 46-48 e smithfield, london, united kingdom.

Recent news